Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iroquois homeobox 1 pseudogene 1 (IRX1P1) is annotated as a pseudogene related to the iroquois homeobox gene family, specifically similar in sequence to the IRX1 transcription factor. Pseudogenes are generally DNA sequences similar to functional genes but considered non-functional due to mutations or lack of regulatory elements; they typically do not code for functional proteins. There is no evidence in the provided or indexed literature suggesting that IRX1P1 is an actual protein-coding gene, a receptor, or has any established biological function, disease relevance, therapeutic target potential, or druggability. The term "pseudogene" indicates that IRX1P1 is not believed to encode a functional gene product or participate in normal cellular biology in the way typical therapeutic targets (like receptors, enzymes, or transporters) do. There is no evidence IRX1P1 is a therapeutic target, nor is it involved in disease pathways, nor does it have any reported interactive drugs or mechanisms of action. No aliases, drug interactions, biomarker utility, or safety/therapeutic concerns are found in standard gene and biomedical literature for this entry. The *iroquois homeobox* (IRX) gene family encompasses transcription factors with roles in embryonic patterning, but pseudogenes derived from members of this family, like IRX1P1, are generally non-functional. The query refers to a pseudogene, making it "incorrect" or at least invalid as a therapeutic target according to prevailing definitions in pharmacology and molecular medicine. If a specific function or role for IRX1P1 (as distinct from IRX1) emerges in future research, it is not currently documented in major databases as of the available search and literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iroquois homeobox 1 pseudogene 1 (IRX1P1).